We recently found that VD3 deficient mice survived longer with BCR-ABL Arf-/- ALL (acute lymphoblastic leukemia) than sufficient mice in the absence of chemotherapy. The gene discussed is CDKN2A; the disease is acute lymphoblastic leukemia.